Clinical Trial Update: Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal Burns [Phase 1]

View source ↗

Summary

This update reports the termination of a Phase 1 study evaluating soluble beta-1,3/1,6-glucan for thermal burns.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burns

Drugs mentioned

• Soluble Beta-1,3/1,6-Glucan (soluble beta-1,3/1,6-glucan)

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Burns | Phase 1 | Status: TERMINATED